{
    "cancelStatus": "1",
    "cancelDate": "2017-08-04",
    "cancelReason": [
        "841"
    ],
    "licid": "10000874",
    "validDate": "2019-01-19 00:00:00.000",
    "issueDate": "2009-01-19 00:00:00.000",
    "licKind": "04",
    "oldLicid": null,
    "certNo": "DHA01000087408",
    "prodNameC": "癌思停 注射劑 (瑞士廠)",
    "prodNameE": "Avastin Injection",
    "indicationsName": [
        "１、轉移性大腸直腸癌(mCRC)：Avastin (bevacizumab) 與含有5-fluorouracil為基礎的化學療法合併使用，可以作為轉移性大腸或直腸癌患者的第一線治療。Avastin與含有5-fluorouracil\/leucovorin\/oxaliplatin的化學療法合併使用，可以作為先前接受過以fluoropyrimidine為基礎的化學療法無效且未曾接受過Avastin治療的轉移性大腸或直腸癌患者的治療。Avastin (bevacizumab)與含有fluoropyrimidine-oxaliplatin-為基礎的化學療法合併使用，可以做為第一線已接受過以Avastin併用fluoropyrimidine-irinotecan-為基礎的化療後惡化之轉移性大腸或直腸癌患者的第二線治療。\r\n２、轉移性乳癌(mBC)：Avastin與paclitaxel合併使用，可以做為HER2 (-) 轉移性乳癌患者的第一線治療。\r\n３、惡性神經膠質瘤(WHO第4級) - 神經膠母細胞瘤：Avastin 單獨使用可用於治療曾接受標準放射線治療且含Temozolomide 在內之化學藥物治療失敗之多型性神經膠母細胞瘤(Glioblastoma multiforme)復發之成人患者。\r\n４、晚期、轉移性或復發性非鱗狀非小細胞肺癌 (NSCLC)：Avastin 與carboplatin及paclitaxel合併使用，可以作為無法切除的晚期、轉移性或復發性非鱗狀非小細胞肺癌患者的第一線治療。\r\nAvastin併用erlotinib，可作為無法手術切除的晚期、轉移性或復發性且帶有表皮生長因子受體(EGFR)活化性突變的非鱗狀非小細胞肺癌患者的第一線治療。\r\n５、復發性卵巢上皮細胞、輸卵管或原發性腹膜癌 (Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer)：Avastin與carboplatin及gemcitabine合併使用，可以做為曾接受過第一線含鉑類藥物 (Platinum-based) 化學治療間隔至少6個月再復發 (即，對含鉑藥物具感受性)，且未曾接受過bevacizumab或其他血管內皮細胞生長因子 (VEGF) 抑制劑或血管內皮細胞生長因子接受器之標靶藥物 (VEGF receptor-targeted agents) 治療之復發性卵巢上皮細胞、輸卵管或原發性腹膜癌患者的治療。Avastin與carboplatin及paclitaxel合併使用，接著單獨使用Avastin治療，可以做為對含鉑藥物具感受性之復發性卵巢上皮細胞、輸卵管或原發性腹膜癌患者的治療。Avastin併用paclitaxel、topotecan或pegylated liposomal doxorubicin 可以做為接受過含鉑類藥物 (platinum-based) 化療治療後6個月內再復發 (即，對含鉑藥物具抗藥性)、之前接受不超過2種化療療程且未曾接受過bevacizumab或其他血管內皮細胞生長因子 (VEGF) 抑制劑或血管內皮細胞生長因子接受器之標靶藥物 (VEGF receptor-targeted agents) 之復發性卵巢上皮細胞、輸卵管或原發性腹膜癌患者的治療。\r\n６、持續性、復發性或轉移性之子宮頸癌 (Persistent, Recurrent, or Metastatic Cervical Cancer)：Avastin 與paclitaxel 及cisplatin 合併使用可用於治療持續性、復發性或轉移性之子宮頸癌。Avastin 與paclitaxel 及topotecan 合併使用可用於無法接受含鉑類藥物治療(platinum therapy)患者之 持續性、復發性或轉移性子宮頸癌。\r\n"
    ],
    "does": "2270",
    "packageUnit": [
        {
            "packageSpec": "16毫升",
            "packageUnit": "1A"
        },
        {
            "packageSpec": "100小瓶以下",
            "packageUnit": "03"
        },
        {
            "packageSpec": "4毫升",
            "packageUnit": "1A"
        }
    ],
    "medMCode": "05",
    "maMedCode": null,
    "medDCode": null,
    "ingredientsDesc": [
        "BEVACIZUMAB"
    ],
    "restraintItemsCode": [
        "02"
    ],
    "applicantName": "羅氏大藥廠股份有限公司",
    "applicantAddr": "台北市松山區民生東路三段１３４號９樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "F. HOFFMANN-LA ROCHE LTD.",
            "factoryAddr": "WURMISWEG, CH-4303 KAISERAUGST, SWITZERLAND",
            "factoryCompanyAddr": null,
            "countryCode": "CH",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FCH0257000",
            "factoryInfo": null,
            "qsd": null
        },
        {
            "factoryCode": "2",
            "factoryName": "F. HOFFMANN-LA ROCHE LTD.",
            "factoryAddr": "GRENZACHERSTRASSE 124, CH-4070 BASEL, SWITZERLAND",
            "factoryCompanyAddr": null,
            "countryCode": "CH",
            "processCode": [
                {
                    "value": "81",
                    "name": "bulk"
                }
            ],
            "processCodeStr": "81;bulk",
            "factoryKind": "M",
            "factoryNo": "FCH0258000",
            "factoryInfo": null,
            "qsd": null
        },
        {
            "factoryCode": "2",
            "factoryName": "Roche Singapore Technical Operations Pte.Ltd.",
            "factoryAddr": "10 Tuas Bay Link, 637394 Singapore",
            "factoryCompanyAddr": "",
            "countryCode": "SG",
            "processCode": [
                {
                    "value": "1K",
                    "name": "原料藥製造廠"
                }
            ],
            "processCodeStr": "1K;原料藥製造廠",
            "factoryKind": "M",
            "factoryNo": "FSG0030000",
            "factoryInfo": null,
            "qsd": null
        },
        {
            "factoryCode": "2",
            "factoryName": "GENENTECH, INC.",
            "factoryAddr": "1 ANTIBODY WAY, OCEANSIDE, CA 92056, USA",
            "factoryCompanyAddr": null,
            "countryCode": "US",
            "processCode": [
                {
                    "value": "81",
                    "name": "bulk"
                }
            ],
            "processCodeStr": "81;bulk",
            "factoryKind": "M",
            "factoryNo": "FUS0768000",
            "factoryInfo": null,
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013000800",
            "ingredientsDesc": "BEVACIZUMAB",
            "concentDesc": null,
            "concent": "25.000",
            "concentUnit": "001",
            "seq": "6",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "2",
            "atcCode": "L01XC07"
        },
        {
            "isMain": "1",
            "atcCode": "L01XC07"
        }
    ]
}